Det tilrådes derfor at udvise forsigtighed, hvis disse aktive stoffer gives samtidig, og theophyllinniveauerne bør monitoreres hos patienter, der starter febuxostat- behandling.
Hence caution is advised if these active substances are given concomitantly, and theophylline levels should be monitored in patients starting febuxostat therapy.